Rishab K. Gupta

2.1k total citations
68 papers, 1.6k citations indexed

About

Rishab K. Gupta is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Rishab K. Gupta has authored 68 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Immunology, 28 papers in Molecular Biology and 28 papers in Oncology. Recurrent topics in Rishab K. Gupta's work include Immunotherapy and Immune Responses (35 papers), Monoclonal and Polyclonal Antibodies Research (23 papers) and Cancer Immunotherapy and Biomarkers (14 papers). Rishab K. Gupta is often cited by papers focused on Immunotherapy and Immune Responses (35 papers), Monoclonal and Polyclonal Antibodies Research (23 papers) and Cancer Immunotherapy and Biomarkers (14 papers). Rishab K. Gupta collaborates with scholars based in United States, India and Netherlands. Rishab K. Gupta's co-authors include Donald L. Morton, Leslie A. Wanek, Leland J. Foshag, J. Anne Nizze, Robert M. Elashoff, Sidney H. Golub, Dave S.�B. Hoon, Reiko F. Irie, Reynold Yee and Hungyi Shau and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and JNCI Journal of the National Cancer Institute.

In The Last Decade

Rishab K. Gupta

67 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rishab K. Gupta United States 20 1.0k 814 716 317 126 68 1.6k
Yao-Tseng Chen United States 20 1.2k 1.2× 657 0.8× 919 1.3× 187 0.6× 128 1.0× 23 1.8k
Luis E. Fernández Cuba 31 1.3k 1.3× 544 0.7× 1.1k 1.6× 577 1.8× 131 1.0× 70 2.2k
Surinder S. Sahota United Kingdom 23 781 0.8× 497 0.6× 606 0.8× 362 1.1× 78 0.6× 61 1.9k
T Honjo Japan 13 747 0.7× 786 1.0× 348 0.5× 172 0.5× 139 1.1× 17 1.5k
Eliezer Gorelik United States 18 697 0.7× 518 0.6× 385 0.5× 152 0.5× 127 1.0× 32 1.4k
Magali Schreyer Switzerland 24 702 0.7× 531 0.7× 747 1.0× 1.2k 3.7× 119 0.9× 40 2.0k
Christian‐Jacques Larsen France 30 496 0.5× 819 1.0× 1.6k 2.2× 180 0.6× 111 0.9× 107 2.6k
Leopoldo Luistro United States 15 1.1k 1.1× 1.0k 1.3× 777 1.1× 281 0.9× 183 1.5× 28 2.2k
Randall J. Brezski United States 23 917 0.9× 551 0.7× 769 1.1× 963 3.0× 139 1.1× 32 2.0k
Richard K. Barth United States 20 1.0k 1.0× 239 0.3× 572 0.8× 305 1.0× 138 1.1× 35 1.8k

Countries citing papers authored by Rishab K. Gupta

Since Specialization
Citations

This map shows the geographic impact of Rishab K. Gupta's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rishab K. Gupta with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rishab K. Gupta more than expected).

Fields of papers citing papers by Rishab K. Gupta

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rishab K. Gupta. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rishab K. Gupta. The network helps show where Rishab K. Gupta may publish in the future.

Co-authorship network of co-authors of Rishab K. Gupta

This figure shows the co-authorship network connecting the top 25 collaborators of Rishab K. Gupta. A scholar is included among the top collaborators of Rishab K. Gupta based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rishab K. Gupta. Rishab K. Gupta is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gupta, Rishab K., et al.. (2024). Analysing accessibility in e-wallet apps for the elderly. International Journal of Business Information Systems. 46(3). 373–410. 1 indexed citations
2.
Glassy, Mark C. & Rishab K. Gupta. (2013). Technical and Ethical Limitations in Making Human Monoclonal Antibodies (An Overview). Methods in molecular biology. 1060. 9–36. 10 indexed citations
3.
4.
Arlen, Myron, et al.. (2010). The Therapeutic Value of Monoclonal Antibodies Directed Against Immunogenic Tumor Glycoproteins. Journal of Cancer. 1. 209–222. 7 indexed citations
5.
Faries, Mark B., Rishab K. Gupta, Xing Ye, et al.. (2007). A Comparison of 3 Tumor Markers (MIA, TA90IC, S100B) in Stage III Melanoma Patients. Cancer Investigation. 25(5). 285–293. 25 indexed citations
6.
7.
Litvak, David A., Rishab K. Gupta, Reynold Yee, et al.. (2003). Endogenous immune response to early- and intermediate-stage melanoma is correlated with outcomes and is independent of locoregional relapse and standard prognostic factors. Journal of the American College of Surgeons. 198(1). 27–35. 29 indexed citations
8.
Chung, Mathew H., Rishab K. Gupta, Anton J. Bilchik, et al.. (2002). Preoperative serum TA90-IC as an adjunct to serum CA 19-9 in the diagnosis of pancreatic malignancy: A pilot study. Current Surgery. 59(2). 194–198. 4 indexed citations
9.
Morton, Donald L., Eddy C. Hsueh, Richard Essner, et al.. (2002). Prolonged Survival of Patients Receiving Active Immunotherapy With Canvaxin Therapeutic Polyvalent Vaccine After Complete Resection of Melanoma Metastatic to Regional Lymph Nodes. Annals of Surgery. 236(4). 438–449. 117 indexed citations
10.
Tsioulias, George J., Rishab K. Gupta, Glenn Tisman, et al.. (2001). Serum TA90 Antigen-Antibody Complex as a Surrogate Marker for the Efficacy of a Polyvalent Allogeneic Whole-Cell Vaccine (CancerVax) in Melanoma. Annals of Surgical Oncology. 8(3). 198–203. 17 indexed citations
11.
Hsueh, Eddy C., et al.. (2000). Does endogenous immune response determine the outcome of surgical therapy for metastatic melanoma?. Annals of Surgical Oncology. 7(3). 232–238. 51 indexed citations
12.
Gupta, Rishab K., et al.. (2000). TA90-IC, A New Marker for Advanced Colon Cancer. Annals of Surgical Oncology. 7(5). 352–356. 17 indexed citations
13.
Hsueh, Eddy C., Rishab K. Gupta, Edwin C. Glass, et al.. (1998). Positron emission tomography plus serum TA90 immune complex assay for detection of occult metastatic melanoma. Journal of the American College of Surgeons. 187(2). 191–197. 17 indexed citations
14.
Kelley, Mark R., Rishab K. Gupta, J. Anne Nizze, et al.. (1996). Immune response to polyvalent melanoma cell vaccine in AJCC stage III melanoma: An immunologic survival model. Annals of Surgical Oncology. 3(5). 437–445. 51 indexed citations
15.
Shau, Hungyi, Rishab K. Gupta, & Sidney H. Golub. (1993). Identification of a Natural Killer Enhancing Factor (NKEF) from Human Erythroid Cells. Cellular Immunology. 147(1). 1–11. 118 indexed citations
16.
Morton, Donald L., Leland J. Foshag, Dave S.�B. Hoon, et al.. (1992). Prolongation of Survival in Metastatic Melanoma After Active Specific Immunotherapy With a New Polyvalent Melanoma Vaccine. Annals of Surgery. 216(4). 463–482. 326 indexed citations
17.
Wong, Jan H., et al.. (1990). Immunochemical characterization of a tumor-associated antigen defined by a monoclonal antibody. Journal of Surgical Research. 48(6). 539–546. 1 indexed citations
18.
Wong, Jan H., Rishab K. Gupta, & Donald L. Morton. (1988). Demonstration of a well‐characterized tumor‐associated antigen on melanoma cell surface. Journal of Surgical Oncology. 38(3). 147–150. 2 indexed citations
19.
Gupta, Rishab K., Hulbert K. B. Silver, Ralph A. Reisfeld, & Donald L. Morton. (1979). Isolation and immunochemical characterization of antibodies from the sera of cancer patients which are reactive against human melanoma cell membranes by affinity chromatography.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 39(5). 1683–95. 14 indexed citations
20.
Gupta, Rishab K. & Donald L. Morton. (1975). Suggestive evidence for in vivo binding of specific antitumor antibodies of human melanomas.. PubMed. 35(1). 58–62. 60 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yao-Tseng Chen Breakdown of academic impact, for papers by Luis E. Fernández Breakdown of academic impact, for papers by Surinder S. Sahota Breakdown of academic impact, for papers by T Honjo Breakdown of academic impact, for papers by Eliezer Gorelik Breakdown of academic impact, for papers by Magali Schreyer Breakdown of academic impact, for papers by Christian‐Jacques Larsen Breakdown of academic impact, for papers by Leopoldo Luistro Breakdown of academic impact, for papers by Randall J. Brezski Breakdown of academic impact, for papers by Richard K. Barth
Rankless by CCL
2026